HXL — Hexima Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Australia's Hexima soars on agreement to buy private AI co
Brief: Hexima Proposes Acquiring Real Thing Entertainment
Brief: Hexima Ltd Says Geoffrey Kempler Appointed As New Chairman
Brief: Hexima Posts Loss For Year Attributable A$1.9 Million
Brief: Hexima Posts HY Loss From Ordinary Activities After Tax Of A$1.6 Million
Brief: Hexima Says Nicole Van Der Weerden To Step Down As CEO
Brief: Hexima Says FY Loss Attributable A$10 Million Versus Loss A$6.9 Million
Brief: Hexima Says Michael Aldridge Resigns As CEO
Hexima at record low on discontinuing fungal nail infection treatment
Brief: Hexima Announces Results Of Phase II Study Of Pezadeftide For Treatment Of Onychomycosis
Australia Stock Exchange release from HEXIMA : Pezadeftide Mode of Action Presentation Released
Australia Stock Exchange release from HEXIMA : Notice of change of interests of substantial holder
Australia Stock Exchange release from HEXIMA : Pezadeftide MOA Presented at AAD Annual Meeting
Australia Stock Exchange release from HEXIMA : Notice of change of interests of substantial holder
Australia Stock Exchange release from HEXIMA : Change of Director's Interest Notice - Dr van der Weerden
Australia Stock Exchange release from HEXIMA : Notification of cessation of securities - HXL
Australia Stock Exchange release from HEXIMA : Notice under Section 708A(5)(e) of Corporations Act
Australia Stock Exchange release from HEXIMA : Application for quotation of securities - HXL
Australia Stock Exchange release from HEXIMA : PRE_NR Ends: 10:17:25